Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

This study has been completed.

Sponsor:

Collaborator:

Bill and Melinda Gates Foundation

Information provided by:

Infectious Disease Research Institute

ClinicalTrials.gov Identifier:

NCT00111553

First received: May 23, 2005

Last updated: February 13, 2007

Last verified: February 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2006
Estimated Primary Completion Date:	No date given